CITURGIA BIOCHEMICALS LTD.
CITURGIA (BSE 506373) · ISIN INE795B01031 · Commodity Chemicals · Est. 1974 · listed 1977 · website
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹0 cr and profit after tax −₹0.08 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹0 cr | −₹0.08 cr | 0.00 | 13 Aug 2026 |
| Q4 FY26 standalone | ₹0 cr | −₹0.26 cr | 0.00 | 30 May 2026 |
| Q3 FY26 standalone | ₹0 cr | −₹0.29 cr | 0.00 | 16 Feb 2026 |
| Q1 FY26 standalone | ₹0 cr | −₹0.08 cr | 0.00 | 23 Sep 2025 |
| Q4 FY25 standalone | ₹0 cr | −₹0.12 cr | −0.01 | 23 Jun 2025 |
| Q3 FY25 standalone | ₹0 cr | −₹0.1 cr | −0.01 | 15 May 2025 |
| Q2 FY25 standalone | ₹0 cr | −₹0.14 cr | −0.01 | 21 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | −₹7.73 cr | ₹6.9 cr | ₹10.47 cr |
| 31 Mar 2025 standalone | −₹6.99 cr | ₹6.83 cr | ₹10.76 cr |
| 30 Sep 2024 standalone | −₹6.77 cr | ₹6.81 cr | ₹10.64 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 99.36% | 0.00% | — | 0.64% |
Latest filings
- OUTCOME OF BOARD MEETING 6 October 2026 · BSE
- UNAUDITED FINANCIAL RESULT FOR QUARTER ENDED 30.06.2026 13 August 2026 · BSE
- AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2026 30 May 2026 · BSE
- UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 31.12.2025 14 February 2026 · BSE
- UNAUDITED FINANCIAL RESULT FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 21 November 2025 · BSE
Other companies in Commodity Chemicals
- Deepak Fertilizers and Petrochemicals Corporation Limited
- POCL Enterprises Limited
- Thirumalai Chemicals Limited
- Jocil Limited
- Transpek Industry Limited
- OCCL Limited
- HINDUSTAN ORGANIC CHEMICALS LT
- Lords Chloro Alkali Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 6 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.